4
Changes in Ownership
ClearPoint Neuro, Inc. Filed Acc 0001285550-23-000029
Options or other derivatives
- GM, Biologics & Drug Delivery acquired 59,258 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
STIGALL L. JEREMY · GM, Biologics & Drug Delivery
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-03-06 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +14,814 | 14,814 | D |
| 2023-03-06 | Grant or award : show line 2 in the form Restricted Stock Units | +44,444 | 44,444 | D |
Loading xslF345X03/wf-form4_167831228291190.xml…